4.7 Article

Proposal for assignment of allele numbers for mobile colistin resistance (mcr) genes

期刊

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
卷 73, 期 10, 页码 2625-2630

出版社

OXFORD UNIV PRESS
DOI: 10.1093/jac/dky262

关键词

-

资金

  1. Intramural Research Program of the National Institutes of Health, National Library of Medicine
  2. Medical Research Council/National Natural Science Foundation of China grant DETER-XDRE-CHINA [MR/P007295/1, 81661138002]
  3. BBSRC [BB/R012776/1] Funding Source: UKRI

向作者/读者索取更多资源

The initial report of the mcr-1 (mobile colistin resistance) gene has led to many reports of mcr-1 variants and other mcr genes from different bacterial species originating from human, animal and environmental samples in different geographical locations. Resistance gene nomenclature is complex and unfortunately problems such as different names being used for the same gene/protein or the same name being used for different genes/proteins are not uncommon. Registries exist for some families, such as bla (ii-lactamase) genes, but there is as yet no agreed nomenclature scheme for mcr genes. The National Center for Biotechnology Information (NCBI) recently took over assigning bla allele numbers from the longstanding Lahey p-ractamase website and has agreed to do the same for mcr genes. Here, we propose a nomenclature scheme that we hope will be acceptable to researchers in this area and that will reduce future confusion.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Immunology

A severe Bacillus Calmette-Guerin vertebral osteomyelitis requiring spinal stabilization: a clinical and microbiological investigation

Giuliana Carrega, Giovanni Riccio, Davide Vallerga, Patrizia Morelli, Ramona Barbieri, Vincenzo Di Pilato, Anna Marchese

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2023)

Article Infectious Diseases

Impact of adherence to procalcitonin antibiotic prescribing guideline recommendations for low procalcitonin levels on antibiotic use

Brian N. Malley, Jonathan Yabes, Elizabeth H. Gimbel, Chung-Chou H. Chang, Donald A. Yealy, Michael Fine, Derek M. Angus, David T. F. Huang

Summary: The Procalcitonin Antibiotic Consensus Trial (ProACT) found that providing a procalcitonin antibiotic prescribing guideline to hospital-based clinicians did not reduce antibiotic use. The study aimed to determine the threshold adherence rate for reducing antibiotic use and to explore opportunities to increase adherence.

BMC INFECTIOUS DISEASES (2023)

Editorial Material Medicine, General & Internal

Treatment and diagnosis of severe KPC-producing Klebsiella pneumoniae infections: a perspective on what has changed over last decades

Daniele Roberto Giacobbe, Vincenzo Di Pilato, Ilias Karaiskos, Tommaso Giani, Anna Marchese, Gian Maria Rossolini, Matteo Bassetti

Summary: Antimicrobial resistance, particularly carbapenem resistance in Gram-negative bacteria, poses a significant global health threat. The emergence of carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) has presented clinicians with unique challenges in managing severe infections. This article discusses the evolution of treatment strategies for KPC-Kp infections over the past decade, guided by clinical evidence and advances in diagnostics.

ANNALS OF MEDICINE (2023)

Article Microbiology

Genomic Epidemiology of Carbapenem-Resistant Klebsiella in Qatar: Emergence and Dissemination of Hypervirulent Klebsiella pneumoniae Sequence Type 383 Strains

Clement Kin-Ming Tsui, Fatma Ben Abid, Khalil Al Ismail, Christi Lee McElheny, Muna Al Maslamani, Ali S. Omrani, Yohei Doi

Summary: The emergence of carbapenem-resistant, hypervirulent Klebsiella pneumoniae is a new threat to health care. We studied the molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae isolates in Qatar using whole-genome sequence data. We also characterized the prevalence and genetic basis of hypervirulent phenotypes and established the virulence potential using a Galleria mellonella model.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

Article Infectious Diseases

A case report of fatal COVID-19 complicated by rapidly progressive sepsis caused by Klebsiella variicola

Rimi Tanii, Sohei Harada, Hiroki Saito, Koh Okamoto, Yohei Doi, Masahiro Suzuki

Summary: This article reports a fatal case of respiratory and bloodstream infection caused by K. variicola complicating severe COVID-19. Co-infection or secondary infection of K. variicola in COVID-19 is likely under-recognized and can be fulminant as in this case.

BMC INFECTIOUS DISEASES (2023)

Article Infectious Diseases

In vivo evolution to echinocandin resistance and increasing clonal heterogeneity in Candida auris during a difficult-to-control hospital outbreak, Italy, 2019 to 2022

Giulia Codda, Edward Willison, Laura Magnasco, Paola Morici, Daniele Roberto Giacobbe, Antonella Mencacci, Daniele Marini, Malgorzata Mikulska, Matteo Bassetti, Anna Marchese, Vincenzo Di Pilato

Summary: A difficult-to-control outbreak of Candida auris is ongoing in a large tertiary care hospital in Liguria, Italy, where it first emerged in 2019. In a retrospective analysis, 503 cases of C. auris carriage or infection were observed between July 2019 and December 2022. Genomic surveillance identified putative cases that no longer occurred as part of one defined outbreak and the emergence of echinocandin (pandrug) resistance following independent selection of FKS1S639F and FKS1F635Y mutants upon prolonged exposure to caspofungin and/or anidulafungin.

EUROSURVEILLANCE (2023)

Article Immunology

Comparison of Biological Activities of BafA Family Autotransporters within Bartonella Species Derived from Cats and Rodents

Kayo Kumadaki, Natsumi Suzuki, Kaoru Tatematsu, Yohei Doi, Kentaro Tsukamoto

Summary: Bartonella species are hemotropic bacteria that cause zoonotic infections in humans. They replicate in vascular endothelial cells and induce vascular proliferation. BafA, a bacteria-secreted protein, is involved in Bartonella-induced vasoproliferation. In this study, the activity of BafA proteins derived from different Bartonella species was compared, and it was found that B. henselae, B. koehlerae, B. clarridgeiae, and B. grahamii induced cell proliferation and tube formation, while B. doshiae showed no activity. These findings suggest that BafA may contribute to the infectivity or pathogenicity of Bartonella species in humans.

INFECTION AND IMMUNITY (2023)

Article Infectious Diseases

Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients

Emily L. Heil, Kimberly C. Claeys, Ellen G. Kline, Tara M. Rogers, Kevin M. Squires, Alina Iovleva, Yohei Doi, Mary Banoub, Mandee M. Noval, Paul M. Luethy, Ryan K. Shields

Summary: This study evaluated the clinical characteristics and outcomes of COVID-19 patients with CRAB infections who received three-drug combination regimens. It found that the use of three-drug regimens resulted in high rates of clinical response and low mortality in severe CRAB infections among COVID-19 patients.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Infectious Diseases

Up-regulation of resident chromosomal fosB gene expression: a novel mechanism of acquired fosfomycin resistance in MRSA

Noemi Aiezza, Alberto Antonelli, Marco Coppi, Vincenzo Di Pilato, Tommaso Giani, Gian Maria Rossolini

Summary: This study investigated the susceptibility and mechanisms of resistance to fosfomycin in a collection of 99 Staphylococcus aureus isolated from hospital-acquired pneumonia cases in Italy. It was found that the resistance rates to fosfomycin were 0% among methicillin-susceptible S. aureus (MSSA) and 22% among methicillin-resistant S. aureus (MRSA). Resistance mechanisms included chromosomal mutations, overexpression of the Tet38 efflux pump gene, and overexpression of a fosB gene encoding a fosfomycin-inactivating enzyme.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Medicine, General & Internal

A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part)

Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, Takumi Imamura, Takuhiro Sonoyama, Genki Ichihashi, Takao Sanaki, Yuko Tsuge, Takeki Uehara, Hiroshi Mukae

Summary: This study aims to evaluate the efficacy and safety of ensitrelvir in patients with mild-to-moderate COVID-19. It is a phase 3 study using a multicenter, randomized, double-blind, placebo-controlled design. The primary endpoint is the time to resolution of COVID-19 symptoms, and key secondary endpoints include the change in SARS-CoV-2 viral RNA and the time to first negative viral titer.

MEDICINE (2023)

Article Immunology

The autotransporter BafA contributes to the proangiogenic potential of Bartonella elizabethae

Natsumi Suzuki, Kayo Kumadaki, Kaoru Tatematsu, Yohei Doi, Kentaro Tsukamoto

Summary: Bartonella elizabethae is a rat-borne zoonotic bacterium that can cause human infectious endocarditis or neuroretinitis. There have been reports of bacillary angiomatosis (BA) caused by this bacterium, raising the possibility that B. elizabethae may also induce vasoproliferation. However, the effects of this bacterium on human vascular endothelial cells (ECs) are still unknown.

MICROBIOLOGY AND IMMUNOLOGY (2023)

Article Immunology

Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group

Michael J. Satlin, David van Duin, Pranita D. Tamma, Thomas P. Lodise, Daria Van Tyne, Keith A. Rodvold, Nadine Rouphael, Scott R. Evans, Vance G. Fowler, Toshimitsu Hamasaki, Robin Patel, Lauren Komarow, Keri Baum, Maria Souli, Nyssa Schwager, Robert A. Bonomo, Yohei Doi

Summary: Addressing antibacterial-resistant gram-negative infections is a priority of the Antibacterial Resistance Leadership Group. The focus of investigation has evolved from elucidating the epidemiology of these infections to improving patient care through clinical trials of optimizing pharmacokinetics and of novel therapies.

CLINICAL INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape

Daniele Roberto Giacobbe, Cristina Marelli, Greta Cattardico, Chiara Fanelli, Alessio Signori, Gabriele Di Meco, Vincenzo Di Pilato, Malgorzata Mikulska, Maria Mazzitelli, Anna Maria Cattelan, Carlo Pallotto, Daniela Francisci, Alessandra Calabresi, Andrea Lombardi, Andrea Gori, Valerio Del Bono, Chiara Aldieri, Angela Raffaella Losito, Francesca Raffaelli, Andrea Cortegiani, Marta Milazzo, Filippo Del Puente, Emanuele Pontali, Francesco Giuseppe De Rosa, Silvia Corcione, Alessandra Mularoni, Giovanna Russelli, Mauro Giacomini, Flavia Badalucco Ciotta, Chiara Oltolini, Francesco Saverio Serino, Elena Momesso, Michele Spinicci, Lucia Graziani, Carlo Torti, Enrico Maria Trecarichi, Marco Merli, Federico D'Amico, Anna Marchese, Antonio Vena, Matteo Bassetti

Summary: The impact of carbapenem resistance on mortality in patients with Klebsiella pneumoniae bloodstream infection was assessed. The study found that carbapenem-resistant patients had a higher mortality rate, but it was not dependent on the type of therapy.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Genetics & Heredity

Insight into Antibiotic Synergy Combinations for Eliminating Colistin Heteroresistant Klebsiella pneumoniae

Sahaya Glingston Rajakani, Basil Britto Xavier, Adwoa Sey, El Bounja Mariem, Christine Lammens, Herman Goossens, Youri Glupczynski, Surbhi Malhotra-Kumar

Summary: This study utilizes population analysis profiling (PAP) and time-kill assay for the detection of heteroresistance in K. pneumoniae and for evaluating the association between in vitro regrowth and heteroresistance. The mechanisms of colistin resistance and the ability of combination therapies to suppress resistance selection were also analysed.
Article Critical Care Medicine

Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG

Daniele Roberto Giacobbe, Silvia Dettori, Vincenzo Di Pilato, Erika Asperges, Lorenzo Ball, Enora Berti, Ola Blennow, Bianca Bruzzone, Laure Calvet, Federico Capra Marzani, Antonio Casabella, Sofia Choudaly, Anais Dartevel, Gennaro De Pascale, Gabriele Di Meco, Melissa Fallon, Louis-Marie Galerneau, Miguel Gallego, Mauro Giacomini, Adolfo Gonzalez Saez, Luise Haensel, Giancarlo Icardi, Philipp Koehler, Katrien Lagrou, Tobias Lahmer, P. Lewis White, Laura Magnasco, Anna Marchese, Cristina Marelli, Mercedes Marin-Arriaza, Ignacio Martin-Loeches, Armand Mekontso-Dessap, Malgorzata Mikulska, Alessandra Mularoni, Anna Nordlander, Julien Poissy, Giovanna Russelli, Alessio Signori, Carlo Tascini, Louis-Maxime Vaconsin, Joel Vargas, Antonio Vena, Joost Wauters, Paolo Pelosi, Jean-Francois Timsit, Matteo Bassetti

Summary: This study describes the characteristics of ICU patients undergoing diagnostic workup for PJP, and finds that PJP is most common in non-HIV patients. The results also suggest that combining serum BDG with respiratory Pneumocystis PCR can improve the accuracy of PJP diagnosis.

CRITICAL CARE (2023)

暂无数据